Bendroflumethiazide

Riik: Uus-Meremaa

keel: inglise

Allikas: Medsafe (Medicines Safety Authority)

Toimeaine:

Bendroflumethiazide 2.5mg;  ;  

Saadav alates:

Ipca Pharma (NZ) Pty Limited

INN (Rahvusvaheline Nimetus):

Bendroflumethiazide 2.5 mg

Annus:

2.5 mg

Ravimvorm:

Tablet

Koostis:

Active: Bendroflumethiazide 2.5mg     Excipient: Lactose Purified talc Starch Stearic acid

Ühikuid pakis:

Blister pack, PVC/PVDC, 14 tablets

Klass:

Prescription

Retsepti tüüp:

Prescription

Valmistatud:

Ipca Laboratories Limited

Näidustused:

Bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.

Toote kokkuvõte:

Package - Contents - Shelf Life: Blister pack, PVC/PVDC - 14 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC - 28 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 500 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 1000 tablets - 24 months from date of manufacture stored at or below 25°C

Loa andmise kuupäev:

2006-06-28